ONL Therapeutics
ID: 5291809ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to helping patients see the future.
5
Funding Rounds
$164.3m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company ONL Therapeutics has raised a total of $111.9m in funding over 5 rounds.
Key Insights:
- ONL Therapeutics September 2024 Series D Funding Round: $65m
- ONL Therapeutics Series B round, January 2022: $46.9m
- ONL Therapeutics, Inc. funding round, August 2019: $3m
- ONL Therapeutics, Inc. funding round, October 2020: $2m
- ONL Therapeutics, Inc. funding round, December 2020: $47.36m
Industries
ONL Therapeutics is active in the following industries: